Table 1

Parvovirus B19 infected patients; clinical details, B19 virus markers, and associated cytokine alleles

Acute infectionFollow up
Clinical manifestation, B19 markerNo.AlleleNo.Allele
†Odds ratio (OR), 4.83; 95% confidence interval (CI), 1.70 to 13.76; p=0.005; ‡OR, 3.44; 95% CI, 0.89 to 13.30; p=0.12; §OR, 2.75; 95% CI, 1.03 to 7.37; p=0.04; ¶OR, 2.89; 95% CI, 0.81 to 11.36; p=0.11; ††OR, 2.19; 95% CI, 0.76 to 6.62; p=0.10.
IFNγ, interferon γ; IL, interleukin; NS1, non-structural protein 1; TGFβ1, transforming growth factor β1; VP, viral protein.
Skin rash15TGFβ1 +869*T†0
Arthritis2410
Fatigue1811
Thrombocytopenia22
Transient aplastic crisis, hereditary spherocytosis10
Lymphadenopathy21
Myalgia10
Mother with fetal death2NA
Serum anti-B19 VP1/2 IgM360
Serum anti-B19 VP1/2 IgG3535
Serum B19 virus DNA349IL-6 –174*G‡
Serum anti-B19 NS1 IgG614IFNγ +874*T§
IL-10 −819/−592*TA¶
TGFβ1 +869*C††